Articles liés à SCN2A-Related Disorders
Synopsis
SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
- ÉditeurCambridge University Press
- Date d'édition2025
- ISBN 10 100953033X
- ISBN 13 9781009530330
- ReliureRelié
- Langueanglais
- Nombre de pages96
- ÉditeurGeorge Jr. Alfred L.
- Coordonnées du fabricantnon disponible
Acheter neuf
Afficher cet article
EUR 74,85
EUR 4,74 expédition depuis Royaume-Uni vers France
Destinations, frais et délais
Résultats de recherche pour SCN2A-Related Disorders
Image d'archives
SCN2A-Related Disorders (Elements in Genetics in Epilepsy)
Edité par
Cambridge University Press, 2025
ISBN 10 : 100953033X
ISBN 13 : 9781009530330
Neuf
Couverture rigide
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9781009530330_new
Quantité disponible : Plus de 20 disponibles
Image d'archives
SCN2A-Related Disorders (Elements in Genetics in Epilepsy)
Edité par
Cambridge University Press, 2025
ISBN 10 : 100953033X
ISBN 13 : 9781009530330
Neuf
Couverture rigide
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur 394660754
Quantité disponible : 3 disponible(s)
Image d'archives
SCN2A-Related Disorders
Edité par
Cambridge University Press, 2025
ISBN 10 : 100953033X
ISBN 13 : 9781009530330
Neuf
Couverture rigide
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : Brand New. 75 pages. 6.00x0.25x9.00 inches. In Stock. This item is printed on demand. N° de réf. du vendeur __100953033X
Quantité disponible : 1 disponible(s)
Image d'archives
SCN2A-Related Disorders (Elements in Genetics in Epilepsy)
Edité par
Cambridge University Press, 2025
ISBN 10 : 100953033X
ISBN 13 : 9781009530330
Neuf
Couverture rigide
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur 18401716295
Quantité disponible : 3 disponible(s)
Image fournie par le vendeur
SCN2A-Related Disorders
Edité par
Cambridge University Press, 2025
ISBN 10 : 100953033X
ISBN 13 : 9781009530330
Neuf
Couverture rigide
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. N° de réf. du vendeur 9781009530330
Quantité disponible : 1 disponible(s)
Image d'archives
SCN2A-Related Disorders (Hardcover)
Edité par
Cambridge University Press, Cambridge, 2025
ISBN 10 : 100953033X
ISBN 13 : 9781009530330
Neuf
Couverture rigide
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : new. Hardcover. SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9781009530330
Quantité disponible : 1 disponible(s)
Image d'archives
SCN2A-Related Disorders (Hardcover)
Edité par
Cambridge University Press, Cambridge, 2025
ISBN 10 : 100953033X
ISBN 13 : 9781009530330
Neuf
Couverture rigide
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Évaluation du vendeur 3 sur 5 étoiles
Hardcover. Etat : new. Hardcover. SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9781009530330
Quantité disponible : 1 disponible(s)
Image d'archives
SCN2A-Related Disorders (Hardcover)
Edité par
Cambridge University Press, Cambridge, 2025
ISBN 10 : 100953033X
ISBN 13 : 9781009530330
Neuf
Couverture rigide
Vendeur : Grand Eagle Retail, Fairfield, OH, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : new. Hardcover. SCN2A encodes a voltage-gated sodium channel (designated NaV1.2) vital for generating neuronal action potentials. Pathogenic SCN2A variants are associated with a diverse array of neurodevelopmental disorders featuring neonatal or infantile onset epilepsy, developmental delay, autism, intellectual disability and movement disorders. SCN2A is a high confidence risk gene for autism spectrum disorder and a commonly discovered cause of neonatal onset epilepsy. This remarkable clinical heterogeneity is mirrored by extensive allelic heterogeneity and complex genotype-phenotype relationships partially explained by divergent functional consequences of pathogenic variants. Emerging therapeutic strategies targeted to specific patterns of NaV1.2 dysfunction offer hope to improving the lives of individuals affected by SCN2A-related disorders. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. This Element provides a review of the clinical features, genetic basis, pathophysiology, pharmacology and treatment of these genetic conditions authored by leading experts in the field and accompanied by perspectives shared by affected families. This title is also available as Open Access on Cambridge Core. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9781009530330
Quantité disponible : 1 disponible(s)